Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
9,298,756
-
Total 13F shares
-
1,706,896
-
Share change
-
+1,706,873
-
Total reported value
-
$7,065,761
-
Price per share
-
$4.14
-
Number of holders
-
32
-
Value change
-
+$7,065,666
-
Number of buys
-
31
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA) as of Q3 2025
As of 30 Sep 2025 Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,706,896 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, BML Capital Management, LLC, VANGUARD GROUP INC, Simplify Asset Management Inc., Propel Bio Management, LLC, TANG CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Pathstone Holdings, LLC, and BlackRock, Inc..
This table shows 32 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.